LINC02726

Across TCGA pan-cancer cohorts, LINC02726 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02726’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02726 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02726 is over-expressed in tumor.

BRCA and LIHC are the cancer types where LINC02726 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02726 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.083	.001	4	view →
LIHC	All	All	+0.060	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02726–BRCA

Open the BRCA breakdown →